CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients
Clinical trial NCT05061654 · WITHDRAWN
Trial details
- NCT number
- NCT05061654
- Sponsor
- Hamad Medical Corporation
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2024-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.